The cyclin-dependent kinase inhibitor flavopiridol inhibits glycogen phosphorylase and affects glucose metabolism.

被引：0
|
作者：
Kaiser, AU
Nishi, K
Walsh, DA
Gorin, FA
Bradbury, EM
Schnier, JB
机构：
[1] Univ Calif Davis, Dept Biol Chem, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：3754S / 3754S
页数：1
相关论文
共 50 条
  • [1] The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase
    Kaiser, A
    Nishi, K
    Gorin, FA
    Walsh, DA
    Bradbury, EM
    Schnier, JB
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 386 (02) : 179 - 187
  • [2] Flavopiridol, a cyclin-dependent kinase inhibitor
    Lansiaux, A
    Bailly, C
    BULLETIN DU CANCER, 2000, 87 (10) : 697 - 701
  • [3] Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment
    Baghel, Uttam Singh
    Kriplani, Priyanka
    Patel, Neelam M.
    Kaur, Manpreet
    Sharma, Kapil
    Meghani, Monika
    Sharma, Abhay
    Singh, Deeksha
    Singh, Bhawani
    Setzer, William N.
    Sharifi-Rad, Javad
    Calina, Daniela
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
  • [4] Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol
    Shapiro, GI
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4270S - 4275S
  • [5] Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development
    Zhai, SP
    Senderowicz, AM
    Sausville, EA
    Figg, WD
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (05) : 905 - 911
  • [6] Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials
    Senderowicz, AM
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) : 313 - 320
  • [7] Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site
    Oikonomakos, NG
    Schnier, JB
    Zographos, SE
    Skamnaki, VT
    Tsitsanou, KE
    Johnson, LN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) : 34566 - 34573
  • [8] Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical Trials
    Adrian M. Senderowicz
    Investigational New Drugs, 1999, 17 : 313 - 320
  • [9] Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy
    Tan, AR
    Swain, SM
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 77 - 85
  • [10] Gene profiling and the cyclin-dependent kinase inhibitor flavopiridol: What's in a name?
    Grant, S
    Dent, P
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (07) : 873 - 875
12345